dc.contributor.author | Pike, Eva | |
dc.contributor.author | Hamidi, Vida | |
dc.contributor.author | Sæterdal, Ingvil Von Mehren | |
dc.contributor.author | Odgaard-Jensen, Jan | |
dc.contributor.author | Klemp, Marianne | |
dc.date.accessioned | 2017-10-03T07:30:21Z | |
dc.date.available | 2017-10-03T07:30:21Z | |
dc.date.created | 2017-09-18T14:21:16Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | BMJ Open. 2017, 7 . | |
dc.identifier.issn | 2044-6055 | |
dc.identifier.uri | http://hdl.handle.net/11250/2457900 | |
dc.language.iso | eng | |
dc.relation.uri | http://bmjopen.bmj.com/content/bmjopen/7/8/e014880.full.pdf | |
dc.title | Multiple treatment comparison of seven new drugs for patients with advanced malignant melanoma: a systematic review and health economic decision model in a Norwegian setting | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 18 | |
dc.source.volume | 7 | |
dc.source.journal | BMJ Open | |
dc.identifier.doi | 10.1136/bmjopen-2016-014880 | |
dc.identifier.cristin | 1494874 | |
cristin.unitcode | 7502,7,2,5 | |
cristin.unitcode | 7502,0,0,0 | |
cristin.unitname | Legemidler og helseøkonomi | |
cristin.unitname | Folkehelseinstituttet | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |